Balyasny Asset Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.98M | Buy |
|
|||||
|
2025
Q1 | $578K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $390K | Buy |
|
|||||
|
2024
Q2 | $327K | Sell |
|
|||||
|
2024
Q1 | $280K | Sell |
|
|||||
|
2023
Q4 | $622K | Sell |
|
|||||
|
2023
Q3 | $794K | Buy |
|
|||||
|
2023
Q2 | $25.6K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $46K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $3.6M | Buy |
|
|||||
|
2021
Q4 | $412K | Sell |
|
|||||
|
2021
Q3 | $3.12M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $2.9M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $5.76M | Sell |
|
|||||
|
2019
Q1 | $5.83M | Buy |
|
|||||
|
2018
Q4 | $3.28M | Buy |
|
|||||
|
2018
Q3 | $823K | Buy |
|
|||||
|
2018
Q2 | – | Hold |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $1.73M | Sell |
|
|||||
|
2017
Q3 | $19M | Buy |
|
|||||
|
2017
Q2 | $9.99M | Buy |
|
|||||
|
2017
Q1 | $10.3M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $500K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $201K | Buy |
|